AGÕæÈ˹ٷ½

STOCK TITAN

[8-K] Performant Healthcare, Inc. Reports Material Event

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

On June 18, 2025, Performant Healthcare, Inc. (Nasdaq: PHLT) held its 2025 Annual Meeting of Stockholders with an 86.58% quorum (67,801,465 shares present or represented). The meeting covered two routine governance items:

  • Election of three Class I directors—James LaCamp, Shantanu Agrawal, and Simeon M. Kohl—each received at least 93.7% of votes cast for, ensuring board continuity through the 2028 Annual Meeting.
  • Ratification of independent auditor—Baker Tilly US, LLP was confirmed for the fiscal year ending December 31, 2025 with 99.96% shareholder support (65,621,257 for; 13,650 against; 2,166,558 abstain).

No other business, financial results, or strategic actions were disclosed. The filing is limited to Item 5.07 voting results and does not signal any material operational or financial change.

Il 18 giugno 2025, Performant Healthcare, Inc. (Nasdaq: PHLT) ha tenuto l'Assemblea Annuale degli Azionisti 2025 con un quorum dell'86,58% (67.801.465 azioni presenti o rappresentate). L'assemblea ha trattato due punti ordinari di governance:

  • Eletti tre membri del Consiglio di Amministrazione di Classe I—James LaCamp, Shantanu Agrawal e Simeon M. Kohl—che hanno ricevuto ciascuno almeno il 93,7% dei voti favorevoli, garantendo la continuità del consiglio fino all'Assemblea Annuale 2028.
  • Ratifica del revisore indipendente—Baker Tilly US, LLP è stato confermato per l'esercizio fiscale terminante il 31 dicembre 2025 con il 99,96% di supporto da parte degli azionisti (65.621.257 favorevoli; 13.650 contrari; 2.166.558 astenuti).

Non sono state comunicate altre questioni, risultati finanziari o azioni strategiche. Il documento riguarda esclusivamente i risultati della votazione dell'Item 5.07 e non indica alcun cambiamento operativo o finanziario significativo.

El 18 de junio de 2025, Performant Healthcare, Inc. (Nasdaq: PHLT) celebró su Junta Anual de Accionistas 2025 con un quórum del 86,58% (67,801,465 acciones presentes o representadas). La reunión abordó dos asuntos rutinarios de gobernanza:

  • Elección de tres directores de la Clase I—James LaCamp, Shantanu Agrawal y Simeon M. Kohl—cada uno recibió al menos el 93,7% de los votos a favor, asegurando la continuidad del consejo hasta la Junta Anual de 2028.
  • Ratificación del auditor independiente—Baker Tilly US, LLP fue confirmado para el ejercicio fiscal que termina el 31 de diciembre de 2025 con un 99,96% de apoyo de los accionistas (65,621,257 a favor; 13,650 en contra; 2,166,558 abstenciones).

No se divulgaron otros asuntos, resultados financieros ni acciones estratégicas. La presentación se limita a los resultados de la votación del Punto 5.07 y no indica ningún cambio operativo o financiero material.

2025ë…� 6ì›� 18ì�, Performant Healthcare, Inc. (나스ë‹�: PHLT)ëŠ� 2025ë…� ì—°ë¡€ 주주ì´íšŒë¥� 86.58%ì� ì¶œì„ë¥�(67,801,465ì£� ì¶œì„ ë˜ëŠ” 위임)ë¡� 개최했습니다. 회ì˜ì—서ëŠ� ë‘� 가지 ì¼ë°˜ì ì¸ 거버넌스 안건ì� 다뤄졌습니다:

  • 3ëª…ì˜ í´ëž˜ìŠ� I ì´ì‚¬ 선출—James LaCamp, Shantanu Agrawal, Simeon M. KohlëŠ� ê°ê° 찬성í‘� 93.7% ì´ìƒì� 받아 2028ë…� ì—°ë¡€ì´íšŒê¹Œì§€ ì´ì‚¬íš� ì—°ì†ì„±ì„ 확보했습니다.
  • ë…립 ê°ì‚¬ì� 승ì¸â€”Baker Tilly US, LLPê°€ 2025ë…� 12ì›� 31ì� 종료ë˜ëŠ” 회계연ë„ì—� 대í•� 주주 99.96%ì� 지지(찬성 65,621,257; 반대 13,650; 기권 2,166,558)ë¡� 확정ë˜ì—ˆìŠµë‹ˆë‹�.

기타 사업, 재무 ê²°ê³¼ ë˜ëŠ” ì „ëžµì � 조치ëŠ� 공개ë˜ì§€ 않았습니ë‹�. 제출 서류ëŠ� 항목 5.07 투표 ê²°ê³¼ì—� 한정ë˜ë©°, 중대í•� ìš´ì˜ ë˜ëŠ” 재무 변화는 없습니다.

Le 18 juin 2025, Performant Healthcare, Inc. (Nasdaq : PHLT) a tenu son Assemblée Générale Annuelle 2025 avec un quorum de 86,58% (67 801 465 actions présentes ou représentées). La réunion a porté sur deux points de gouvernance ordinaires :

  • Élection de trois administrateurs de la Classe I—James LaCamp, Shantanu Agrawal et Simeon M. Kohl—chacun ayant obtenu au moins 93,7 % des voix pour, assurant la continuité du conseil d'administration jusqu'à l'Assemblée Générale de 2028.
  • Ratification de l'auditeur indépendant—Baker Tilly US, LLP a été confirmé pour l'exercice fiscal se terminant le 31 décembre 2025 avec le soutien de 99,96 % des actionnaires (65 621 257 pour ; 13 650 contre ; 2 166 558 abstentions).

Aucune autre affaire, résultat financier ou action stratégique n'a été divulguée. Le dépôt se limite aux résultats du vote de l'Item 5.07 et ne signale aucun changement opérationnel ou financier important.

Am 18. Juni 2025 hielt Performant Healthcare, Inc. (Nasdaq: PHLT) seine Hauptversammlung 2025 mit einem Quorum von 86,58% (67.801.465 Aktien anwesend oder vertreten) ab. Die Versammlung behandelte zwei routinemäßige Governance-Punkte:

  • Wahl von drei Direktoren der Klasse I—James LaCamp, Shantanu Agrawal und Simeon M. Kohl—jeder erhielt mindestens 93,7 % der abgegebenen Stimmen ´Úü°ù, was die Kontinuität des Vorstands bis zur Hauptversammlung 2028 sichert.
  • Bestätigung des unabhängigen Wirtschaftsprüfers—Baker Tilly US, LLP wurde ´Úü°ù das Geschäftsjahr bis zum 31. Dezember 2025 mit 99,96 % Aktionärsunterstützung bestätigt (65.621.257 da´Úü°ù; 13.650 dagegen; 2.166.558 Enthaltungen).

Weitere Geschäfte, finanzielle Ergebnisse oder strategische Maßnahmen wurden nicht bekannt gegeben. Die Einreichung beschränkt sich auf die Abstimmungsergebnisse des Punktes 5.07 und signalisiert keine wesentlichen operativen oder finanziellen Veränderungen.

Positive
  • High shareholder support (â‰�93.7%) for all director nominees signals investor confidence in current leadership.
  • Auditor ratified with 99.96% approval, reinforcing trust in financial reporting integrity.
Negative
  • None.

Insights

TL;DR: Routine AGM; strong director and auditor support—neutral impact.

Shareholders backed all directors with >93% support and overwhelmingly ratified Baker Tilly, indicating confidence in current leadership and audit oversight. Turnout above 86% is healthy, but governance items are standard; no activist opposition or unexpected vote patterns emerged. The disclosure does not alter the investment thesis and is unlikely to move the stock.

TL;DR: Housekeeping 8-K; no material catalysts—maintain stance.

The notice confirms status quo board composition and auditor engagement. With no capital allocation, guidance, or operational updates, the filing has minimal impact on valuation models or risk profile. Investors can view the outcome as a sign of shareholder alignment but should not expect near-term price reaction.

Il 18 giugno 2025, Performant Healthcare, Inc. (Nasdaq: PHLT) ha tenuto l'Assemblea Annuale degli Azionisti 2025 con un quorum dell'86,58% (67.801.465 azioni presenti o rappresentate). L'assemblea ha trattato due punti ordinari di governance:

  • Eletti tre membri del Consiglio di Amministrazione di Classe I—James LaCamp, Shantanu Agrawal e Simeon M. Kohl—che hanno ricevuto ciascuno almeno il 93,7% dei voti favorevoli, garantendo la continuità del consiglio fino all'Assemblea Annuale 2028.
  • Ratifica del revisore indipendente—Baker Tilly US, LLP è stato confermato per l'esercizio fiscale terminante il 31 dicembre 2025 con il 99,96% di supporto da parte degli azionisti (65.621.257 favorevoli; 13.650 contrari; 2.166.558 astenuti).

Non sono state comunicate altre questioni, risultati finanziari o azioni strategiche. Il documento riguarda esclusivamente i risultati della votazione dell'Item 5.07 e non indica alcun cambiamento operativo o finanziario significativo.

El 18 de junio de 2025, Performant Healthcare, Inc. (Nasdaq: PHLT) celebró su Junta Anual de Accionistas 2025 con un quórum del 86,58% (67,801,465 acciones presentes o representadas). La reunión abordó dos asuntos rutinarios de gobernanza:

  • Elección de tres directores de la Clase I—James LaCamp, Shantanu Agrawal y Simeon M. Kohl—cada uno recibió al menos el 93,7% de los votos a favor, asegurando la continuidad del consejo hasta la Junta Anual de 2028.
  • Ratificación del auditor independiente—Baker Tilly US, LLP fue confirmado para el ejercicio fiscal que termina el 31 de diciembre de 2025 con un 99,96% de apoyo de los accionistas (65,621,257 a favor; 13,650 en contra; 2,166,558 abstenciones).

No se divulgaron otros asuntos, resultados financieros ni acciones estratégicas. La presentación se limita a los resultados de la votación del Punto 5.07 y no indica ningún cambio operativo o financiero material.

2025ë…� 6ì›� 18ì�, Performant Healthcare, Inc. (나스ë‹�: PHLT)ëŠ� 2025ë…� ì—°ë¡€ 주주ì´íšŒë¥� 86.58%ì� ì¶œì„ë¥�(67,801,465ì£� ì¶œì„ ë˜ëŠ” 위임)ë¡� 개최했습니다. 회ì˜ì—서ëŠ� ë‘� 가지 ì¼ë°˜ì ì¸ 거버넌스 안건ì� 다뤄졌습니다:

  • 3ëª…ì˜ í´ëž˜ìŠ� I ì´ì‚¬ 선출—James LaCamp, Shantanu Agrawal, Simeon M. KohlëŠ� ê°ê° 찬성í‘� 93.7% ì´ìƒì� 받아 2028ë…� ì—°ë¡€ì´íšŒê¹Œì§€ ì´ì‚¬íš� ì—°ì†ì„±ì„ 확보했습니다.
  • ë…립 ê°ì‚¬ì� 승ì¸â€”Baker Tilly US, LLPê°€ 2025ë…� 12ì›� 31ì� 종료ë˜ëŠ” 회계연ë„ì—� 대í•� 주주 99.96%ì� 지지(찬성 65,621,257; 반대 13,650; 기권 2,166,558)ë¡� 확정ë˜ì—ˆìŠµë‹ˆë‹�.

기타 사업, 재무 ê²°ê³¼ ë˜ëŠ” ì „ëžµì � 조치ëŠ� 공개ë˜ì§€ 않았습니ë‹�. 제출 서류ëŠ� 항목 5.07 투표 ê²°ê³¼ì—� 한정ë˜ë©°, 중대í•� ìš´ì˜ ë˜ëŠ” 재무 변화는 없습니다.

Le 18 juin 2025, Performant Healthcare, Inc. (Nasdaq : PHLT) a tenu son Assemblée Générale Annuelle 2025 avec un quorum de 86,58% (67 801 465 actions présentes ou représentées). La réunion a porté sur deux points de gouvernance ordinaires :

  • Élection de trois administrateurs de la Classe I—James LaCamp, Shantanu Agrawal et Simeon M. Kohl—chacun ayant obtenu au moins 93,7 % des voix pour, assurant la continuité du conseil d'administration jusqu'à l'Assemblée Générale de 2028.
  • Ratification de l'auditeur indépendant—Baker Tilly US, LLP a été confirmé pour l'exercice fiscal se terminant le 31 décembre 2025 avec le soutien de 99,96 % des actionnaires (65 621 257 pour ; 13 650 contre ; 2 166 558 abstentions).

Aucune autre affaire, résultat financier ou action stratégique n'a été divulguée. Le dépôt se limite aux résultats du vote de l'Item 5.07 et ne signale aucun changement opérationnel ou financier important.

Am 18. Juni 2025 hielt Performant Healthcare, Inc. (Nasdaq: PHLT) seine Hauptversammlung 2025 mit einem Quorum von 86,58% (67.801.465 Aktien anwesend oder vertreten) ab. Die Versammlung behandelte zwei routinemäßige Governance-Punkte:

  • Wahl von drei Direktoren der Klasse I—James LaCamp, Shantanu Agrawal und Simeon M. Kohl—jeder erhielt mindestens 93,7 % der abgegebenen Stimmen ´Úü°ù, was die Kontinuität des Vorstands bis zur Hauptversammlung 2028 sichert.
  • Bestätigung des unabhängigen Wirtschaftsprüfers—Baker Tilly US, LLP wurde ´Úü°ù das Geschäftsjahr bis zum 31. Dezember 2025 mit 99,96 % Aktionärsunterstützung bestätigt (65.621.257 da´Úü°ù; 13.650 dagegen; 2.166.558 Enthaltungen).

Weitere Geschäfte, finanzielle Ergebnisse oder strategische Maßnahmen wurden nicht bekannt gegeben. Die Einreichung beschränkt sich auf die Abstimmungsergebnisse des Punktes 5.07 und signalisiert keine wesentlichen operativen oder finanziellen Veränderungen.

0001550695FALSE00015506952025-06-182025-06-18

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K 
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 18, 2025 
 
Performant Healthcare, Inc.
(Exact name of registrant as specified in its charter)

Delaware 001-35628 20-0484934
(State or other jurisdiction
of incorporation)
 (Commission
File Number)
 (IRS Employer
Identification No.)
900 South Pine Island Road,
Plantation, FL 33324
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: (925) 960-4800

N/A
(Former name or former address, if changed since last report.)
 
 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
    
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s) Name of exchange on which registered
Common Stock, par value $.0001 per share
PHLT
The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b–2 of the Securities Exchange Act of 1934 (§ 240.12b–2 of this chapter).     

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.



Item 5.07 Submission of Matters to a Vote of Security Holders.

The 2025 Annual Meeting of Stockholders (the “Annual Meeting”) of Performant Healthcare, Inc. (the “Company”) was held on June 18, 2025 at 2:00 PM, EDT, at the Courtyard Fort Lauderdale Weston located at 2000 N Commerce Parkway, Weston, Florida 33326. A total of 67,801,465 shares of the Company’s common stock were present in person or by proxy at the Annual Meeting, representing 86.58% of the total number of shares outstanding and entitled to vote at the meeting.

The number of votes cast for, against or withheld, as well as abstentions and broker non-votes, as applicable, with respect to each proposal considered at the Annual Meeting is as follows:


Proposal No. 1 – Election of Directors

The Company's stockholders elected three Class I directors to serve until the 2028 Annual Meeting of Stockholders or until their successors are elected and qualified:

Nominee:ForWithheldBroker Non-Votes
James LaCamp
59,145,2384,120,7134,535,514
Shantanu Agrawal
60,889,6342,376,3174,535,514
Simeon M. Kohl
61,048,0642,217,8874,535,514



Proposal No. 2 – Ratification of the Appointment of Our Independent Registered Public Accounting Firm for 2025

The Company’s stockholders ratified the appointment of Baker Tilly US, LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2025:

ForAgainstAbstainBroker Non-Votes
65,621,25713,6502,166,5580


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: June 23, 2025
 
PERFORMANT HEALTHCARE, INC.
By: /s/Simeon Kohl
 Simeon Kohl
 Chief Executive Officer

FAQ

What was the quorum at Performant Healthcare's (PHLT) 2025 Annual Meeting?

Shareholders representing 86.58% of outstanding shares were present or represented.

Which directors were elected at PHLT's 2025 AGM?

James LaCamp, Shantanu Agrawal, and Simeon M. Kohl were elected as Class I directors until 2028.

How did shareholders vote on ratifying Baker Tilly as auditor for 2025?

The proposal passed with 65,621,257 for, 13,650 against, and 2,166,558 abstaining.

Did the 8-K include any financial results or strategic announcements?

No. The filing solely disclosed Item 5.07 voting results; no financial or strategic updates were provided.

Is Performant Healthcare considered an emerging growth company?

No. The 8-K indicates the company did not mark itself as an emerging growth company.
Performant Finl Corp

NASDAQ:PHLT

PHLT Rankings

PHLT Latest News

PHLT Latest SEC Filings

PHLT Stock Data

270.16M
69.31M
8.1%
85.05%
1.28%
Health Information Services
Services-miscellaneous Business Services
United States
PLANTATION